New test centre offers r&d without upfront investment
Danish company Niro has opened its new pharma- ceutical test centre to allow its customers to work on product r&d and process evaluation projects without the need for early investment in plant or expertise. Niro vice president Svenn Ryberg said that the test centre is being developed as part of Niro's brand positioning. 'We aim to work with our customers to identify optimum processing techniques by combining their product know-how and our know-how on spray drying.' The centre is being built to GMP standards with a cleanroom rating of 100,000, with process control that will be fully 21 CFR part 11 compliant. It includes PSD 4, PSD 1 and SD Micro equipment to provide the widest possible range of spray drying technology for realistic testing and easy scale-up to full production. The centre is able to evaluate spray drying processes using both aqueous and organic solvent feeds. Niro hopes that the facility will help customers achieve the best product quality for the chosen drug delivery method with minimal development time and increased security of outcome. Furthermore, test work can be performed during the project implementation phase, giving valuable input to the validation process, providing training for the customer project team, and reducing the commissioning period of the commercial production unit. Enquiry card number: 121